puncture. 5 A randomized study comparing CT fluoroscopy with fluoroscopy alone found that CT fluoroscopy combined with fluoroscopy led to higher successful rates of first puncture, fewer punctures, and shorter procedure times. 6 At times, it may be necessary to access a nondilated biliary system. In these situations, access can often be achieved by directing needle punctures in the vicinity of peripheral branches of the portal vein. In a study evaluating this technique, 35 patients with biliary strictures with nondilated bile ducts, including 24 cases of benign bilioenteric anastomotic strictures, successful access to the biliary tree was achieved in 94.3% of cases. 7 This technique is very helpful for the postliver transplantation patients when early biliary strictures are suspected.
PTC can accurately depict the location and characteristics of biliary strictures in most patients. 8 The appearances and features of BBS in cholangiography can vary depending on the etiology. Most biliary strictures are unifocal and are often iatrogenic (liver transplantation, partial hepatectomy, and bile duct injury). Noniatrogenic causes such as stone disease, pancreatitis, trauma, radiation therapy, portal biliopathy, and idiopathic papillary stenosis can also lead to unifocal strictures. The reasons for multifocal or diffuse bile duct strictures include ischemia (hepatic artery occlusion after liver transplantation) and cholangitis (sclerosing cholangitis, pyogenic cholangitis, tuberculosis, human immunodeficiency virus, parasitosis, autoimmune disease, and immunoglobulin G4-related cholangiopathy). The goals of PTC are to depict the levels of obstruction, evaluate for bile duct stones, define etiologies of cholangitis, and demonstrate bile duct leak. 9 Additional maneuvers such as catheter drainage, balloon dilation, and stent placement can be performed through PTC access.
Percutaneous Transhepatic Catheter Drainage
The goal of catheter drainage of the biliary is to relieve jaundice, control infection, and improve nutritional status, which are all essential for patients in the perioperative period. 10, 11 The decision regarding whether to do more invasive manipulations at the time of initial drainage depends on technical challenges or complications during bile duct catheterization. When cholangitis, bleeding, or infection complicate biliary catheterization, or if the puncture has been technically challenging and time consuming, an external biliary drainage catheter should be placed without further attempts to cross the stricture. 9 Alternatively, if PTC goes smoothly, attempts to cross biliary strictures with guide wires are reasonable. 9, 12 It may not always be easy to cross the strictures by using a conventional 0.035" guidewire. Fidelman introduced a Lunderquist-Ring Torque guidewire with a "stick" formation at the distal end and a "handle" formed on the proximal end to allow torqueing, which is useful for crossing strictures. 9 In circumstances of complete biliary occlusion, needle-knife fistulotomy may be considered to re-establish communication between the biliary tree and bowel. 13 Usually, an external biliary drainage protocol with or without balloon dilation will be undertaken to achieve restoration of biliary patency. [10] [11] [12] [14] [15] [16] [17] [18] Catheter sizes typically range from 7 to 12 Fr and in some instances can be up sized to 14 to 18 Fr. In general, catheter exchange intervals vary from weeks to several months, depending on patient tolerance, physician experience, and evolution of the stricture with catheter drainage. 11, 12, 14, 18 If follow-up cholangiograms show less than 20% residual stenosis and flow contrast material into the small bowel within 30 seconds, drainage is considered to be technically successful. Residual stenosis of more than 20% or drainage of the contrast material into small bowel was more than 30 seconds, drainage catheters should be up sized and internal/external drainage extended for longer periods. 19 There is no strict time algorithm to determine optimum drainage, but once optimum drainage has been achieved, bilirubin levels have normalized and repeat cholangiography suggests biliary patency, a clamp trial of the catheter can be considered. 14 Catheters should be removed if the stricture remained patent, or the patients switched to a more invasive solution such as stent placement or surgical revision if catheter drainage and dilatation fail to achieve the desired results. 14 Recently, large bore catheters of 18 to 20 Fr have been advocated for percutaneous management of BBS, even in postliver transplantation patients. 20 The use of the large bore catheters showed promising rates of stricture resolution; however, this was often achieved at the expense of negative impact on patients' quality of life by extending catheterization time and increasing numbers of interventions. 20, 21 Dual catheter techniques, whereby two catheters are placed via a single puncture site, may offer the ability to achieve optimum drainage with fewer interventions compared with other techniques. Gwon et al described insertion of an 8.5-Fr catheter through the lumen of a 14-Fr catheter and then both catheters across the stricture to achieve a diameter of 22.5 Fr at the stricture site but kept 14 Fr at the puncture site. 16 One of the challenges of percutaneous biliary drainage can be patient discomfort at the puncture site. This is most commonly encountered with right-sided drainage. For the reason, left-sided punctures are often better tolerated than right-sided drainage and are prefers when the anatomy allows. 14 Also, specially designed skin anchoring devices may also improve the quality of life for those who require long-term drainage. 22 
Balloon Dilation
Selection of balloon size should be estimated based on the cholangiogram. Initially, a balloon size slightly less than or equal to bile duct diameter adjacent to the stricture is recommended for initial dilatation to minimize the risk of anastomotic disruption and bile leak. If necessary, larger diameter balloons can be used for subsequent dilations with balloon sizes up to 25 to 30% larger than the estimated diameter of the duct being dilated. 12, 19 Most balloon sizes for BBS range from 4 to 12 mm. 10-12,14-18 Common bile duct strictures can be safely dilated to 10 to 12 mm in an adult. Smaller balloons (4-8 mm) may be necessary for lobar ducts and for the biliary strictures in children. 9, 23 Time intervals between balloon dilations range from 1 to 2 weeks to every 3 months to establish and maintain duct patency. 17, 18 An-gioplasty balloon catheters should always be inflated gradually until the site of narrowing, commonly referred as the "waist" is eliminated (►Fig. 1). Satisfactory dilation is marked by disappearance of the "waist" and restoration of normal bile flow. 24 The use of cutting balloons has been described for refractory biliary strictures, especially those unresponsive to conventional balloon dilatation. Cutting balloons are designed with four longitudinally mounted, 1-cm long microsurgical blades that are exposed during inflation. Several reports suggest that cutting balloon is associated with high success rates and few complications. [25] [26] [27] [28] Mukund et al reported a group of eight cases of biliary strictures treated with cutting balloon with up to 14 months of follow-up free of recurrent biliary obstruction and cholangitis. 25 Further randomized contrast clinical trials are necessary to verify its safety and efficacy.
Long-Term Results of Catheterization and Balloon Dilation
From 2007 to present, eight studies with the mean follow-up time of 34 months to 5.2 years have evaluated the long-term results of balloon dilatation. [10] [11] [12] [14] [15] [16] [17] [18] Most have showed 1-year patency rates of 94 to 100%, while 3-year patency rates range from 71 to 96%. [10] [11] [12] 15, 16, 18 The 5-and 10-year patency rates were 74 to 88 and 67 to 72%, respectively, in two recent studies. 12, 14 However, a retrospective study with 25-year results showed a lower long-term patency of 52, 49, and 41% in 5, 10, and 25 years, respectively. 17 The long-term results of catheterization and balloon dilation are listed in ►Table 1.
Kucukay et al found that there was no difference in longterm patency between patients who underwent successful one-time balloon dilation versus those with successful initial dilatation and two or more subsequent dilations (85.4 vs. 87.9%). As a result, repeated balloon dilation is not recommended when the first procedure is successful. 24 Furthermore, Janssen et al found that restenosis and treatment failure occurred more often in patients who underwent multiple dilatations. They found that factors that led clinically relevant restenosis were the number of strictures and the number of treatments. 12 Between strictures at anastomotic and nonanastomotic sites, Cantwell et al revealed that no significant difference was found in the rate of clinically significant restenosis after the first treatment. 17 Regarding the patients with orthotopic liver transplantation (OLT), the risk of stricture recurrence for those with no history of OLT was found to be lower than that for patients with a history of OLT. 14 
Biliary Stents
Self-expandable metallic stent (SEMS) provides an optional solution for refractory or recurrent BBS, especially when patients are unsuitable or unwilling to undergo surgery. 29, 30 However, the use of SEMS for BBS remains controversial at present because of the high rate of stent obstruction secondary to epithelial hyperplasia. 31 Furthermore, stent removal may be difficult or impossible once they become embedded in the wall due to epithelial hyperplasia. 32 The introduction of fully covered SEMS (FCSEMS) offers solutions to overcome these limitations. Covered metal stents have a metallic skeleton covered by a biocompatible, layer of synthetic material which is resistant to the effects of bile, gastric, and pancreatic secretions. The covered layer prevents the stent from becoming embedded and makes stent very smooth and easy to remove. 33, 34 In addition, FCSEMS can be implanted and removed by either endoscopic or percutaneous methods. Gwon et al reported 68 cases of BBS treated with percutaneously placed FCSEMS and showed technical success of 98.5% (67/68) for stent placement and 98.5% (66/67) for stent removal. 35 After a mean stent indwelling period of 5.8 months and mean follow-up period of 36 months, the primary patency rates at 1, 2, 3, 4, and 5 years reached 91, 89, 76, 68, and 68%, respectively. 35 Another function of FCSEMS is to block the bile leaks, especially for the bilioenteric anastomotic strictures combined with leakage. Gwon et al reported 100% clinical success of 11 cases of postoperative bile leaks treated with retrievable FCSEMS. 36 Recently, multicenter clinical trials showed that endoscopic placed FCSEMS was safe and effective for BBS. 37, 38 Although FCSEMSs are effective in minimizing endothelial overgrowth, their smooth surfaces may contribute to stent migration which is reportedly as high rate as 16.2%. 35 The application of biodegradable stents in BBS may help overcome the migration problems associated with FCSEMS. The currently available biodegradable biliary stent is made of polydioxanone, which is proved by the Food and Drug Administration as a biodegradable material for clinical use. Delivery systems range in diameter from 11 to 15 Fr and the degradation time, which occurs by hydrolytic processes, is approximately 3 to 6 months. 39, 40 Recently, Mauri et al reported a multicenter clinical study of percutaneously implanted of biodegradable stents for 107 patients with refractory BBS. The technical success was 98%. Stent migration was observed only in 2/107 cases (2%). The stricture recurrence rates at 1, 2, and 3 years were 7.2, 26.4, and 29.4%, respectively. Although they reported no major complications, restenosis was found to be associated with subsequent cholangitis and biliary stones. 41 
Other Percutaneous Techniques for Management of Benign Biliary Strictures Magnetic Compression Anastomosis
Magnetic compression anastomosis (MCA) is a technique whereby a pair of cylindrical samarium-cobalt magnets that measure 4 Â 10 mm are used to treat high grade or complete biliary strictures. Two magnets are introduced by percutaneous and endoscopic access separately and approximate each other on different sides of the stricture. Compression by the approximated magnets caused ischemic necrosis of the tissue between the magnets, forming a fistula. Jang et al reported their clinical effectiveness treating both biliobiliary and bilioenteric anastomoses. 42, 43 Percutaneous Transhepatic Cholangioscopy Percutaneous transhepatic cholangioscopy (PTCS) offers the option of direct endoluminal visualization of the biliary tree for diagnostic and therapeutic interventions. 44 Biliary stones are the most commonly encountered disorder with biliary strictures. Treatment of BBS can be difficult in the setting of choledocholithiasis. Percutaneous transhepatic endoscopic biliary holmium laser lithotripsy (PTBL) can be helpful in this setting. Rimon et al reported a group of patients with biliary stones who failed conventional treatment that were treated with PTBL. In 6/22 patients with stone disease in the setting of biliary strictures, PTBLs were able to achieve complete fragmentation of the stones with no major complication occurred. 45 
Percutaneous Transjejunal Biliary Intervention
Percutaneous transjejunal biliary intervention (PTJBI) is an alternative technique for access to the biliary system to treat benign biliary diseases in patients with a Roux-en-Y hepaticojejunostomy. Fontein et al reported the largest series that evaluated efficacy of PTJBI for BBS and stone retrieval. In this procedure, the Roux loop is punctured under fluoroscopic guidance, using surgical clips as a landmark, and a guidewire advanced into the afferent limb. Then, an 8-to 10-Fr sheath is advanced over the guidewire into the afferent limb, thus providing access to biliary strictures and stones if a guidewire crosses the hepaticojejunal anastamosis. 46 Mansueto et al treated a group of patients with hepaticojejunostomy dehiscence in which initial access to the biliary tree was achieved by PTJBI, followed by a rendezvous technique to establish percutaneous biliary drainage to the jejunum. 47 
Complications
Hemorrhage and infection represent the most commonly encountered complications of percutaneous biliary interventions. An analysis of 419 cases of percutaneous transhepatic biliary drainages indicated an overall complication rate of 9.31%, including bleeding (2.86%), cholangitis (1.67%), and sepsis (1.43%). 48 Transarterial embolization is an effective management for bleeding associated with active extravasation or pseudoaneurysm of the hepatic artery. 15, 17, 49 Biliary leak and bilomas are less frequently encountered and can usually be managed by drainage. 50 Drainage-related complications are reported as high as 21.4%, including occlusion, dislocation, and cholangitis. 51 Stent-related complications include stent migration and perforation. 52 Procedure-related mortality was reported as 2%. Multivariate analysis revealed this was related to the preprocedure presence of ascites, high C-reactive protein, and a high white cell count. 53 Percutaneous Management of Benign and Postoperative Biliary Strictures Shao, Arellano 33 several interventional techniques. Catheterization and balloon dilation are the primary recommended methods for treating BBS, with the satisfactory long-term results. Newer techniques, such as SEMSs, fully covered, and biodegradable stents are options when strictures are refractory treatment or fail to resolve by conventional methods. Innovative and novel techniques such as MCA, PTCS, and PTJBI may be helpful in the management of BBS. However large, multicenter, randomized contrast clinical trials are necessary to further evaluate their long-term efficacy and safety.
Conclusion

